Duplex ultrasound has provided a greater understanding of the anatomy and pathophysiology of superficial venous insufficiency and has aided in the development of image-guided endovenous ablative therapy. The authors review ultrasound techniques for the evaluation of the superficial venous system and its utility in guiding and evaluating the results of endovenous ablation.
Dr. Khilnani
is the Director of Fibroid Treatment and the Co-Director of Vein
Treatment and
Dr. Min
is the Director of Vein Treatment, Cornell Vascular, Weill
Medical College of Cornell University, New York, NY.
Recent advances in the diagnosis and treatment of superficial
venous insufficiency (SVI) have provided new enthusiasm for the
care of this prevalent medical condition. Many of the advances
resulted from the liberal use of duplex ultrasound (DUS), which
fostered a greater understanding of the anatomy and pathophysiology
of this disease. In addition, the use of DUS has, in part, led to
the development of safe and effective image-guided endovenous
methods to ablate incompetent truncal veins. In this presentation,
we will review the techniques of ultrasound (US) evaluation of the
superficial venous system and demonstrate its utility in guiding
and evaluating the results of endovenous ablation.
Indications for US evaluation
All patients with varicose veins require an ultrasound of the
superficial venous system to map the pattern of venous incompetence
prior to making treatment recommendations. Even though many
patients present with varicose vein patterns that are very
suggestive of a certain pathophysiology, the patterns of varicose
veins seen on physical examination associated with different forms
of venous incompetence overlap sufficiently to commonly result in
errors of treatment selection. Patients with spider veins,
particularly those in the lateral thigh area, do not routinely
require US evaluation. However, when the spider veins are found in
the distribution of a large truncal vein, such as the great
saphenous vein (GSV), it is recommended that DUS be performed. If
truncal vein refiux is identified and is contributory in these
cases, treatment of this refiux may be warranted prior to treatment
of the spider veins.
Diagnostic duplex US technique and findings
The duplex examination to evaluate for SVI has been well
described.
1
Typically, a DUS unit with a 7.5 -MHz probe is used. The goals of
the examination are to define the incompetent veins and to
determine if they are responsible for the patient's clinical
problem. When evaluating patients for refiux, the examination
should be performed in the physiologically appropriate standing
position. The patient is usually positioned on a stand to elevate
the legs to facilitate the performance of the study. The patient is
asked to turn his/her leg outward to facilitate scanning of the
inner thigh and calf. Generally, the examination begins at the
saphenofemoral junction (SFJ). The femoral vein is evaluated for
obstruction and refiux. Next, the GSV is followed from its junction
down toward the ankle. The relationship of the GSV and its
tributaries to any abnormal veins is assessed by tracing their
course. It is important to be aware of the standard tributary
anatomy of the GSV and to recognize the frequent variations that
are found
1,2
(Figure 1). One particularly common variant is the anterior
accessory GSV (AAGSV), which courses anterior to the path of the
GSV. It has been described in the past as a long anterior
circumfiex vein or as a duplicated GSV. This vein joins the GSV
just below the SFJ and then courses obliquely down the anterior
thigh. It is often responsible for anterior thigh varicose veins.
It may rejoin the GSV in the lower thigh.
A careful search for significant incompetent perforating veins
(IPVs) into the GSV should be made. Often the caliber of the GSV
will increase at the level of a significant IPV, and this may be a
clue to pursue careful imaging at this level to identify this
important source of refiux. Incompetent perforating veins are
frequently identified at the peripheral or lower end of an
incompetent vein segment; these can be called reentry IPVs. Many
IPVs will normalize after correction of the truncal or nontruncal
refiux feeding them.
The caliber of the GSV is then assessed. Normally the vein is ≤4
mm in diameter. Veins >7 mm have a high incidence of refiux.
Refiux can occur in smaller veins, but even if found, it is usually
clinically unimportant. Peripheral to the takeoff of incompetent
tributary veins, the caliber of the GSV often decreases. Any vein
segment suspected of having refiux by size or by relationship to
varicose veins is then evaluated with color and pulse wave Doppler
(PWD) to directly visualize the direction of fiow. Color is very
helpful to quickly exclude refiux, but can over- or underestimate
its severity. All suspicious segments should be examined with PWD.
Refiux can be easily documented by looking for antegrade fiow
followed by retrograde fiow after a quick, firm compression of a
peripheral segment of the GSV. Generally, when evaluating the GSV,
compression of the calf should lead to augmen- tation of antegrade
fiow. When evaluating the AAGSV, compression of the lower thigh is
most useful. Upon release of compression, little if any retrograde
fiow should be noted. While the literature denotes ≥0.5 seconds of
retrograde fiow as the criterion for pathological refiux, several
seconds of retrograde fiow is typically seen in patients with
venous incompetence
1
(Figure 2).
Next, the patient is turned to face away from the examiner, and
the small saphenous vein (SSV) is evaluated. The pro-cess of
evaluation is similar to that of the GSV. This includes tracing the
course of the SSV vein, assessing its size and its relationship to
any varicose veins, and also assessing the popliteal vein. The
anatomy of the SSV and its cephalic termination are quite variable.
In approximately 50% to 70% of cases, the SSV terminates into the
popliteal vein roughly 2 cm above the popliteal crease. However,
more cephalad extension of this vein is common. Often it will
extend several centimeters up the posterior thigh to terminate in a
perforating vein (PV). Occasionally, it will extend even more
cephalad toward the buttock crease before terminating into a PV. A
relatively common variant, the vein of Giacomini, is a connection
between the GSV and the SSV. This vein runs subfacially in the
posterior thigh and can be a pathway of venous incompetence leading
to the posterior thigh and calf varicose veins.
3
In some cases, DUS in patients with varicose veins will not
identify truncal vein incompetence. These nontruncal pathways are
much more common in multiparous women and include pudendal and
gluteal vein incompetence
4
(Figure 1). Occasionally, these sources- especially the pudendal
source-can lead to GSV incompetence more peripherally in the leg.
Other important sources of nontruncal refiux include IPVs in the
medial and lateral thigh and popliteal fossa that can usually be
identified with DUS.
DUS in guiding sclerotherapy
Ultrasound-guided therapy for venous disease began more than 15
years ago with the introduction of US-guided sclero-therapy (UGS).
Currently, UGS is occasionally used to direct sclerotherapy of
deeper superficial veins and IPVs. For some time, there was a great
deal of enthusiasm for UGS of the saphenous veins. However, high
rates of recanalization reported by most investigators led to more
cautious application of this technique. Recent interest in the use
of foam sclero-sants for UGS of both the incompetent tributary
veins and the saphenous trunks may lead to greater utilization of
UGS.
UGS utilizes the principles of sclero-therapy and the advantages
of image guidance. Accurate identification of in-competent vein
segments and distinction from adjoining normal veins and arteries
improve the success and minimize the risk associated with
sclerotherapy of deeper and larger veins. Ultrasound guidance is
first used to identify the target veins for therapy that often
cannot be identified with the naked eye. Once selected, the vein
can be punctured with real-time US guidance. This can be done with
a longitudinal or transverse ap-proach. During injection,
microbubbles in the sclerosant produce echoes that visibly confirm
an intravascular injection. This phenomenon is more pronounced when
foam sclerosants are used. After injection, successfully treated
veins often go into spasm. Follow-up US several weeks after
injection often reveals noncompressible veins filled with trapped
blood. This usually resorbs over several months, at which point the
successfully sclerosed vein becomes a cord that may be difficult to
find with US.
DUS guidance of endovenous thermal ablation
Duplex ultrasound-guided endovenous thermal ablation (EVTA) is
an ex-tension of the use of US to guide sclero- therapy. Laser and
radiofrequency EVTA of the saphenous veins and their primary
tributaries utilizes catheters inserted into the abnormal vein
peripherally and ad-vanced to the most central level of refiux.
These catheters are then activated (creating endovenous heat) and
withdrawn across the segment to be treated. The goals of these
therapies are to permanently occlude the incompetent vein segments.
5,6
Duplex ultrasound is used first to identify the location for
venous access. This is generally at the lowest or most peripheral
level of the primary incompetent segment. Typically, the GSV
refiuxes from the SFV down toward the calf, where its incompetent
fiow spills into a tributary that fills varicosities. In these
cases, the access will be at the level of the takeoff of this
tributary. The GSV is usually small further down the calf; the size
transition seen on ultrasound guides where to access the GSV.
Occasionally, the puncture and treatment can be applied to
superficial tributaries that remain relatively straight and
parallel to the course of the GSV. In this case, these so-called
superficial accessory saphenous veins can be accessed directly at
the most peripheral part of the straight segment.
After access, DUS is used to position the catheter to the
highest level to be ablated. In the case of the GSV, this is
usually at the SFJ. With the laser catheter, a long sheath is
usually inserted into the femoral vein and the laser fiber is
placed through it. In the case of the SFJ, the fiber and sheath are
withdrawn together until the tip of the fiber is at or just below
the SFJ (Figure 3). This is best performed by imaging in a
longitudinal projection. With the radiofrequency (RF) device, a
short sheath is placed and the RF catheter inserted. The RF device
can track over a wire. The device is advanced to the SFJ, and its
tines are exposed, producing a characteristic appearance.
4
The next step in EVTA is the delivery of tumescent anesthesia
(TA), a dilute, large-volume local anesthetic, into the perivenous
space of the vein to be treated. Tumescent anesthesia is used not
only to make the procedure painless but also to insulate the vein
from the surrounding nerves, arteries, and skin as well as to
efface the lumen of the vein to maximize circumferential energy
transfer to the vein wall. Duplex ultrasound guidance of the needle
used to inject the TA fiuid in the perivenous saphenous sheath is
essential to maximize the effectiveness and efficiency of its
delivery. Successful TA results in a perivenous hypoechoic halo
that obliterates the vein lumen from the puncture site to the
highest end of the treated segment (Figure 4).
Thermal ablation begins only after DUS is used to confirm once
again that the tip of the EVTA tool is at the desired starting
point. When the laser fiber is activated, steam bubbles can be seen
at the tip of the bare fiber, adding confidence to the position of
the tip as seen with US. After this, observation with DUS usually
has little utility. Some operators perform DUS immediately after
EVTA to confirm success, but the TA and vein spasm usually
obliterate the lumen of the treated vessel even without thermal
energy delivery. Echo-genic bubbles can be seen in the residual
lumen and can sometimes even be seen in the surrounding tissue, but
these are of no clinical importance.
Periodic DUS should always be performed to evaluate the treated
vein segments after EVTA.
5,7
This is generally done in the first few weeks after therapy, again
a few months later, and then at yearly intervals. Duplex ultrasound
should also be performed to evaluate for the cause of any recurrent
varicose veins. In the first several weeks after therapy, the
treated veins will either be smaller or the same size as they were
prior to treatment, with a thick wall and nearly obliterated lumen
(Figure 5). There should be no fiow in the entire treated vein
segment. This should be distinguished from the appearance of a
thrombosed vein that in the first few weeks would appear as a
central hypoechoic to moderately hyper-echoic filling defect in a
vein, which is at least as enlarged as the pretreatment diameter.
Partially thrombosed veins may have some eccentric fiow. After
several months to a year, successfully treated vein segments will
usually be difficult to identify or will be significantly smaller
than the vein prior to treatment and will have no fiow.
5,7
Most treatment failures will be evident in the first few weeks as
either thrombosed vein segments that subsequently recanalize or as
veins that are unchanged compared with the preliminary examination.
Most treatment failures are apparent under DUS as a central segment
of vein, beginning near the SFJ, or the saphenopopliteal junction
in the case of SSV ablation, extending downward to the takeoff of
an incompetent tributary. Below this level, the vein is often
successfully treated.
Conclusion
Duplex ultrasound is an integral part of the modern evaluation
and management of patients with SVI. Precise anatomical and fiow
mapping is required prior to planning treatment in all patients
with varicose veins. Treatment with EVTA, and occasionally
sclerotherapy, also requires precise monitoring with DUS. All
patients treated with ETVA should be followed for several months
after the procedure to confirm its success. It is incumbent upon
all physicians involved in caring for patients with SVI to become
familiar with the use of DUS to optimally care for their
patients.